Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for atracurium-related hemodynamic changes during general anesthesia
IRCT20170108031818N2Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Hydrocortisone with Placebo (2 arms). Primary endpoints: Hemodynamic changes, Bronchospasm and 1 more. Started Apr 2022; status: completed.
02
Drugs
hydrocortisone
Beyond the preview
Go deeper on IRCT20170108031818N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170108031818N2.